Misclassification of Survey Responses and Black-White Disparity in Mammography Use, Behavioral Risk Factor Surveillance System, 1995-2006 by Njai, Rashid et al.
VOLUME 8: NO. 3 MAY 2011
Suggested citation for this article: Njai R, Siegel PZ, Miller 
JW,  Liao  Y.  Misclassification  of  survey  responses  and 
black-white  disparity  in  mammography  use,  Behavioral 
Risk Factor Surveillance System, 1995-2006. Prev Chronic 
Dis 2011;8(3). http://www.cdc.gov/pcd/issues/2011/may/10_
0109.htm. Accessed [date].
PEER REVIEWED
Abstract
Introduction
The validity of self-reported data for mammography differ 
by race. We assessed the effect of racial differences in the 
validity of age-adjusted, self-reported mammography use 
estimates from the Behavioral Risk Factor Surveillance 
System  (BRFSS)  from  1995  through  2006  to  determine 
whether  misclassification  (inaccurate  survey  question 
response) may have obscured actual racial disparities.
Methods
We adjusted BRFSS mammography use data for age by 
using 2000 census estimates and for misclassification by 
using the following formula: (estimated prevalence − 1 + 
specificity) / (sensitivity + specificity − 1). We used values 
reported in the literature for the formula (sensitivity = 
0.97 for both black and white women, specificity = 0.49 and 
0.62, respectively, for black and white women).
Results
After adjustment for misclassification, the percentage of 
women aged 40 years or older in 1995 who reported receiv-
ing a mammogram during the previous 2 years was 54% 
among white women and 41% among black women, com-
pared with 70% among both white and black women after 
adjustment  for  age  only.  In  2006,  the  percentage  after 
adjustment  for  misclassification  was  65%  among  white 
women and 59% among black women compared with 77% 
among white women and 78% among black women after 
adjustment for age only.
Conclusion
Self-reported  data  overestimate  mammography  use  — 
more  so  for  black  women  than  for  white  women.  After 
adjustment for respondent misclassification, neither white 
women nor black women had attained the Healthy People 
2010 objective (≥70%) by 2006, and a disparity between 
white and black women emerged.
Introduction
Behavioral Risk Factor Surveillance System (BRFSS) data 
show that in 1995 the percentage of both black and white 
women aged 40 years or older who had received a mammo-
gram during the past 2 years was near the Healthy People 
2010 objective of 70% (objective 3-13) (1). By 1997, the 
BRFSS race-specific prevalence estimates had increased 
and  remained  above  the  Healthy  People  2010  objective 
through 2006 (2). Racial differences in the validity of these 
self-reported data can, however, result in misclassification 
(defined as an inaccurate answer) of survey responses that 
may obscure true black-white disparities in mammogra-
phy use rates (3-8).
A recent meta-analysis of studies that measured the race-
specific validity of survey questions about self-reported 
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mammography  use  against  documented  sources,  such 
as medical and billing records, found that the specificity 
of survey questions that measure mammography use is 
lower among black women than white women (4). In this 
article, specificity refers to the probability that a woman 
who does not have a documented mammogram actually 
reports she did not have a mammogram, whereas sen-
sitivity refers to the probability that a woman who does 
have  a  documented  mammogram  actually  reports  she 
did  have  a  mammogram.  After  adjusting  race-specific 
mammography use rates from the 2000 National Health 
Interview Survey for sensitivity and specificity, Rauscher 
and  colleagues  found  increases  of  up  to  15  percentage 
points in the disparity between black and white women; 
estimates for the percentage of women who reported hav-
ing had a mammogram in the past 2 years fell from 68% 
to 37% for black women and from 72% to 58% for white 
women (4).
Death rates from breast cancer remain higher for black 
women than for white women, even though breast can-
cer  incidence  is  higher  among  white  women  (9).  This 
observation  has  been  referred  to  as  the  breast  cancer 
incidence-mortality  paradox  (10).  Mammograms  are  a 
key tool for detecting breast cancer at an early, treatable 
stage and thereby reducing death rates from the disease; 
yet black women are more likely than white women to 
have  advanced-stage  cancer  at  diagnosis.  BRFSS  data, 
however, consistently indicate that black women receive 
mammograms as frequently as white women (11).
The objectives of this study were to adjust BRFSS mam-
mography  data  for  misclassification  and  measure  the 
extent  to  which  this  misclassification  resulted  in  over-
estimates  of  mammography  use  rates  and  might  have 
obscured a disparity between black and white women. We 
included data from a 12-year period, 1995 through 2006, 
and compared adjusted rates with the Healthy People 2010 
objective that at least 70% of women aged 40 years or older 
should have had a mammogram within the past 2 years. 
We also discuss how adjusting mammography use data 
for misclassification may help to explain part of the breast 
cancer incidence-mortality paradox.
Methods
BRFSS  is  the  largest  state-based  telephone  survey  of 
the civilian, noninstitutionalized adult population. Using 
SAS-callable  SUDAAN  version  9.2  (RTI  International, 
Research  Triangle  Park,  North  Carolina)  we  weighted 
BRFSS  data  for  probability  of  selection  and  to  match 
the age-, race-, and sex-specific populations from annu-
ally  adjusted  intercensal  estimates.  The  survey,  which 
uses  a  complex  sampling  design,  collects  self-reports 
of  health  risk  behaviors  monthly  in  all  50  states,  the 
District of Columbia, and 3 US territories: Guam, Puerto 
Rico, and the US Virgin Islands. Detailed descriptions of 
the methods, questionnaires, and other technical survey 
details  are  available  from  the  BRFSS  website  (www.
cdc.gov/brfss/index.htm).  We  used  the  Women’s  Health 
Module  of  BRFSS,  which  includes  mammography  use 
questions and was administered as part of the core survey 
each year from 1995 through 1999 and in even-numbered 
years since 2000. The number of black and white women 
aged 40 years or older who answered the mammography 
use questions increased from 39,025 in 1995 to 156,982 in 
2006. For the years when the Women’s Health Module was 
not included in the BRFSS core survey — 2001, 2003, and 
2005 — we used the midpoint of the prevalence estimates 
from the previous and following years. Chi-square analysis 
was used to assess differences in demographic characteris-
tics between black and white women (P < .001).
A meta-analysis of 12 studies including more than 4,000 
white women and 1,000 black women reported that the 
sensitivity  of  self-reported  mammography  questions  for 
use within the previous 2 years was 0.97 for both black 
and white US women aged 40 years or older. Specificity, 
however, was lower for black women (0.49) than for white 
women  (0.62)  (4).  These  studies  compared  survey  data 
of black and white women’s self-reported mammography 
use with a review of medical or billing records to confirm 
whether  the  self-report  was  accurate  (12-15).  Women 
included in these 12 studies were aged 40 years or older, 
generally represented convenience samples from a range 
of low socioeconomic status (SES) to middle-upper SES 
groups, and were selected from intervention, clinic, and 
Medicare populations.
To understand the relationship between black and white 
estimates for mammography use independent of age, we 
first  age-adjusted  the  weighted  prevalence  estimates  to 
the  2000  US  census  standard  population.  Next,  using 
the  values  of  sensitivity  and  specificity  obtained  from 
Rauscher  (4),  we  adjusted  the  age-adjusted  prevalence 
estimates for misclassification, using the following formula 
(15): final-adjusted prevalence = (estimated prevalence − 1 
+ specificity) / (sensitivity + specificity − 1). Thus, for black 
women, the formula was (estimated prevalence − 1 + 0.49) VOLUME 8: NO. 3
MAY 2011
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/ (0.97 + 0.49 – 1), and for white women it was (estimated 
prevalence − 1 + 0.62) / (0.97 + 0.62 – 1).
For  these  analyses,  only  non-Hispanic  black  and  non-
Hispanic  white  women  aged  40  years  or  older  who 
responded  to  the  mammography  questions  in  BRFSS 
were included. Respondents’ race was based on self-report. 
Race is included as a characteristic of interest because it 
is a proxy for potentially unequal psychosocial and other 
environmental exposures (16). Race is subsequently used 
to examine the existence of an absolute disparity between 
white  and  black  women  following  necessary  statistical 
adjustment of race-specific prevalence estimates for mam-
mography  use.  Chi-square  tests  were  used  to  examine 
white-black differences in demographic data. In addition, 
age-adjusted and final-adjusted (adjusted for both age and 
misclassification)  annual  BRFSS  prevalence  estimates 
were tested by using linear regression trend analysis to 
determine whether time, race, and time-race interaction 
statistically affect the estimated prevalence of mammog-
raphy use.
Results
The distributions for all selected demographic characteris-
tics differed by race (P < .001) (Table). Black women were 
younger, had a higher prevalence of employment and a 
lower prevalence of health insurance coverage, were less 
educated, and had lower incomes than their white coun-
terparts.
Among women aged 40 years or older who participated 
in the 1995 BRFSS, 70% of both white and black women 
reported having had a mammogram during the previous 
2  years  (Figure).  After  adjustment  for  misclassification, 
the prevalence in 1995 fell to 54% among whites and 41% 
among blacks. In 2006, adjustment for misclassification 
resulted in a drop from 77% to 65% for white women and 
from 78% to 59% for black women. Based on final adjusted 
results,  prevalence  estimates  for  both  black  and  white 
women  in  1995  were  substantially  below  the  Healthy 
People 2010 objective of 70%. Estimates were higher in 
subsequent years, but by 2006, they had not reached the 
70% objective for either group.
The age-adjusted prevalence of mammography use among 
black  women  from  1995  through  2006  was  generally 
equal to or slightly higher than that among white women 
(Figure). After adjustment for misclassification, however, 
prevalence  estimates  were  on  average  8.95  percentage 
points  (t  =  −6.75,  P  <  .001)  lower  overall  among  black 
women than among white women. Linear regression trend 
analysis of adjusted prevalence estimates (regressing year 
and race on use) also showed a significant positive rela-
tionship (β = 1.19, standard error = .19, P < .001) between 
time (years) and mammography use in the past 2 years 
when  controlling  for  race.  In  additional  trend  analyses 
there was no significant interaction between year and race 
(t = 1.13, P = .27) over time (ie, the slopes of the 2 regres-
sion lines were not significantly different); thus the rate of 
increase in mammography use over time was the same for 
black and white women from 1995 through 2006.
Discussion
According to unadjusted and age-adjusted BRFSS data, 
there was little to no disparity from 1995 through 2006 
between the percentages of black and white women aged 
40 years or older who had a mammogram during the past 
2 years. Also, mammography use rates for both black and 
white women were consistently at or above the Healthy 
People 2010 objective of 70%. However, after adjustment 
for respondent misclassification, mammography use rates 
Figure. Age-adjusted and final-adjusted estimates for mammography use 
among white and black women, Behavioral Risk Factor Surveillance System, 
1995-2006. Data refer to women who reported having a mammogram within 
the past 2 years. Final-adjusted estimates were obtained by adjusting the 
age-adjusted estimates for misclassification using the following formula with 
race-specific specificity (sp) and sensitivity (se) (white se = .97, sp = .62; 
black se = .97, sp = .49): (estimated prevalence − 1 + sp) / (se + sp − 1). 
See formula in Methods. Percentages for 2001, 2003, and 2005 are the 
averages of the previous and following years. Abbreviations: adj., adjusted; 
HP 2010, Healthy People 2010 goal.VOLUME 8: NO. 3
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for neither white women nor black women had attained 
the Healthy People 2010 objective by 2006, and a disparity 
between white and black women emerged.
Lack of a disparity in mammography use between black 
and white women has been widely reported among studies 
that focus on racial, ethnic, and socioeconomic disparities 
(2,17,18). However, the results presented in our study sug-
gest that previous notions of black-white parity in mam-
mography use should be reexamined (13). Women of lower 
SES, immigrant women, black women, and women from 
other minority racial or ethnic groups remain populations 
of concern because of disparities in stage of breast cancer 
at diagnosis and breast cancer death rates (16,19-21). The 
disparity  in  mammography  use  observed  in  our  study 
may help explain racial disparities in stage of breast can-
cer at diagnosis and in breast cancer death rates. Other 
factors  that  might  contribute  to  the  incidence-mortality 
paradox include differences in the biology of the disease 
between black women and white women, differences in 
stage at diagnosis that are unassociated with mammogra-
phy use, and differences in treatment following diagnosis 
(11,21,22).
Lack of access to care — because of high cost, not having a 
usual source of care, or lack of health insurance — remains 
a  barrier  to  mammography  use.  Lower-income,  elderly, 
and immigrant women may encounter barriers because of 
language or health literacy problems. Additional factors 
that may reduce mammography use and contribute to dis-
parities include patient knowledge, attitudes, and cultural 
beliefs (22-24). For example, Rawl and colleagues found 
that white women perceived greater benefits from receiv-
ing a mammogram than did black women (23).
This study has several limitations. Ideally, the measures of 
validity used to adjust BRFSS prevalence estimates would 
be based on studies of nationally representative samples 
of women. Although such data are not available, the stud-
ies included in the meta-analysis by Rauscher et al (4) do 
include white and black women from a spectrum of ages 
(40 years or older), regions, and SES groups. Rauscher et al 
do not report a significant difference between the specific-
ity of self-reported mammography use data for black and 
white women (0.49 vs 0.62); however, the 95% confidence 
intervals for these measures do not overlap (0.42-0.57 vs 
0.61-0.64). The number of studies that measured sensi-
tivity and specificity for black women was limited; thus 
the values obtained by Rauscher et al may be vulnerable 
to sample variation, external generalizability, and other 
sources  of  measurement  error.  Also,  the  application  of 
measures of validity from the random-effects meta-analy-
sis does assume study-to-study variability and suggests 
uncertainty in estimating the underlying parameters (ie, 
sensitivity and specificity) (4).
Additional limitations are that the sensitivity and speci-
ficity  measures  that  we  used  did  not  account  for  SES. 
Although  sensitivity  and  specificity  may  differ  between 
women with higher and lower SES, there is a dearth of 
literature in this area (4,25). The sensitivity and specific-
ity measures also did not account for other factors such 
as  attitudes  and  women’s  knowledge  of  breast  cancer 
and screening mammography. Another limitation is that 
the  BRFSS  questionnaire  (similar  to  other  comparable 
national surveys) does not distinguish whether a woman 
received a mammogram for screening or diagnostic pur-
poses. Finally, the median state and territorial Council 
of  American  Survey  Research  Organizations  response 
rates for BRFSS have been low in recent years; from 2000 
through 2006 they ranged from 49% to 58%. Median coop-
eration rates during the same period ranged from 53% to 
77% (26).
Most  studies  that  have  measured  the  validity  of  mam-
mography survey questions were conducted in the 1990s. 
These studies should be repeated to confirm whether sen-
sitivity and specificity have changed. Such studies should 
be conducted in diverse populations and include an assess-
ment of data sources such as medical and billing records.
In addition to updating validity measures of the standard 
wording in surveys of mammography use, it would also 
be useful to identify alternative wording that might have 
higher validity. Most surveys, including BRFSS and the 
National  Health  Information  Survey,  use  the  following 
introductory  wording:  “These  next  questions  are  about 
mammograms, which are X-ray tests of the breast to look 
for cancer.” In 1992, BRFSS used different introductory 
wording: “I would like to ask you a few questions about 
a medical exam called a mammogram. A mammogram is 
an X-ray of the breast and involves pressing the breast 
between two plastic plates.”
The reported prevalence of mammogram use was lower 
when  this  more  graphic  wording  was  used  than  when 
standard wording was used; this reduction in prevalence 
was greater among black women than white women (27). 
These effects on measured prevalence are consistent with 
the hypothesis that questionnaire language that clarifies VOLUME 8: NO. 3
MAY 2011
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that a mammogram involves “pressing the breast between 
two plastic plates” improves the specificity (ie, results in 
fewer false-positive responses).
Cultural sensitivity and awareness should be applied when 
addressing black-white and other racial/ethnic disparities 
in breast cancer detection and treatment. To be effective, 
interventions designed to overcome persistent inequalities 
must take into account differences in race, culture, lan-
guage, SES, and age (24). Our study reinforces that these 
considerations  can  apply  to  the  validity  of  surveillance 
data as well (4,27). Surveillance, intervention, and policy 
must account for the unique characteristics of women from 
each  racial/ethnic  group.  Increasing  mammography  use 
— especially among underserved populations — remains 
a priority as public health professionals strive to eliminate 
breast  cancer  disparities  and  to  decrease  breast  cancer 
death rates.
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Table
Table. Selected Characteristics of Women Aged 40 Years or Older Who Responded to the Mammography Use Questions in the 
Behavioral Risk Factor Surveillance System, by Race, 1995 and 2006a
Characteristic
White Womenb Black Womenb
1995, % (95% CI), n = 
26,573
2006, % (95% CI), n = 
119,737
1995, % (95% CI), n = 
12,452
2006, % (95% CI), n = 
37,245
Age, y
40-49 32.3 (31.4-33.1) 29.5 (29.0-30.0) 38.3 (35.1-41.5) 36.9 (35.2-38.6)
50-59 21.4 (20.7-22.1) 27.9 (27.4-28.3) 22.5 (20.3-24.8) 28.3 (26.8-29.8)
60-69 21.4 (20.7-22.1) 18.6 (18.3-19.0) 21.5 (19.2-24.0) 17.6 (16.5-18.9)
≥70 25.0 (24.3-25.8) 24.0 (23.6-24.4) 17.8 (15.8-19.9) 17.2 (16.0-18.6)
Employed
Yes 83.8 (82.6-84.9) 83.1 (82.6-83.7) 87.8 (84.7-90.4) 85.9 (84.2-87.5)
No 13.5 (12.5-14.6) 13.7 (13.2-14.3) 4.1 (3.0-5.7) 8.2 (7.0-9.7)
Retired 2.8 (2.4-3.2) 3.1 (2.9-3.4) 8.1 (5.8-11.1) 5.9 (5.0-6.9)
Health insurance
Yes 94.2 (93.8-94.6) 93.2 (93.0-93.5) 86.6 (84.6-88.4) 85.4 (84.2-86.6)
No 5.8 (5.4-6.2) 6.8 (6.5-7.0) 13.4 (11.6-15.4) 14.6 (13.5-15.8)
Education, y
<12 15.7 (15.1-16.3) 7.5 (7.2-7.8) 32.8 (30.1-35.5) 17.8 (16.5-19.2)
12 36.6 (35.7-37.4) 32.2 (31.8-32.7) 32.0 (29.3-34.8) 33.4 (31.8-35.0)
>12 47.8 (46.9-48.7) 60.3 (59.8-60.8) 35.3 (32.0-38.6) 48.8 (47.1-50.5)
Annual household income, $
0-14,999 13.6 (13.1-14.2) 7.6 (7.4-7.9) 25.9 (23.5-28.5) 19.7 (18.4-21.0)
15,000-24,999 20.3 (19.6-21.0) 12.6 (12.3-12.9) 23.5 (21.2-25.9) 20.2 (18.9-21.5)
25,000-49,999 28.5 (27.7-29.3) 23.4 (23.0-23.8) 24.2 (21.1-27.7) 24.8 (23.4-26.3)
≥50,000 21.1 (20.3-21.9) 40.3 (39.8-40.8) 10.6 (9.1-12.5) 22.0 (20.5-23.5)
Not specified 16.6 (16.0-17.2) 16.1 (15.8-16.5) 15.7 (13.9-17.7) 13.4 (12.3-14.5)
 
Abbreviation: CI, confidence interval. 
a Prevalence of all characteristics was different (P < .001, using χ2 analysis) between white and black women in both 1995 and 2006. 
b Unweighted sample sizes, weighted percentages.